XLRN
Alkeon Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,245,412
| Closed | -$214M | – | 171 |
|
|
2021
Q3 | $214M | Sell |
1,245,412
-2,719
| -0.2% | -$468K | 0.36% | 54 |
|
|
2021
Q2 | $157M | Sell |
1,248,131
-473,600
| -28% | -$59.4M | 0.23% | 64 |
|
|
2021
Q1 | $233M | Buy |
1,721,731
+3,310
| +0.2% | +$449K | 0.35% | 46 |
|
|
2020
Q4 | $220M | Buy |
1,718,421
+92,815
| +6% | +$11.9M | 0.36% | 41 |
|
|
2020
Q3 | $183M | Buy |
1,625,606
+125,000
| +8% | +$14.1M | 0.34% | 44 |
|
|
2020
Q2 | $143M | Buy |
1,500,606
+122,656
| +9% | +$11.7M | 0.36% | 47 |
|
|
2020
Q1 | $124M | Buy |
1,377,950
+800,000
| +138% | +$71.9M | 0.53% | 40 |
|
|
2019
Q4 | $30.6M | Sell |
577,950
-366,000
| -39% | -$19.4M | 0.11% | 68 |
|
|
2019
Q3 | $37.3M | Hold |
943,950
| – | – | 0.13% | 64 |
|
|
2019
Q2 | $38.8M | Buy |
943,950
+100,000
| +12% | +$4.11M | 0.15% | 66 |
|
|
2019
Q1 | $39.3M | Buy |
843,950
+470,000
| +126% | +$21.9M | 0.2% | 67 |
|
|
2018
Q4 | $16.3M | Buy |
373,950
+101,621
| +37% | +$4.43M | 0.11% | 73 |
|
|
2018
Q3 | $15.6M | Buy |
+272,329
| New | +$15.6M | 0.07% | 72 |
|